Logo | Name | Σ | Employees | ||
---|---|---|---|---|---|
Helsinn Group Welcome to Helsinn Group's LinkedIn page. This account shall only be used to share news concerning Helsinn. We would like to emphasize that due to the highly regulated nature of the pharma industry, we cannot engage with you online in any discussions concerning our or other companies’ products and/or services, and/or treatment options. It is best to hold such discussions and to seek guidance privately from your healthcare professional. Helsinn is a global pharmaceutical company that builds, manufactures, launches, and commercializes products to improve the quality of life for patients with cancer and chronic disease, with a focus on supportive … Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 8 | 0 | 2 | 400 | |
CAMBOND LIMITED CAMBOND LIMITED is a medical devices company based out of 1 Mackenzie Rd, Cambridge, CAMBRIDGESHIRE, United Kingdom. Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 2 | 0 | 1 | 3 | |
Santhera Pharmaceuticals We are dedicated to developing medicines to meet the needs of patients living with rare diseases. Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular diseases with high unmet medical need. The Company has an exclusive license from ReveraGen for all indications worldwide to AGAMREE® (vamorolone), a dissociative steroid with novel mode of action, which was investigated in a pivotal study in patients with Duchenne muscular dystrophy (DMD) as an alternative to standard corticosteroids. AGAMREE for the treatment of DMD is approved in the U.S. by the … Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 93 | |
Epithelix Provider of cells, 3D tissues and testing services. Epithelix Sàrl is a Swiss biotech company specialized in human tissue engineering. Epithelix provides innovative R&D solutions for the study of human respiratory diseases (e.g. Asthma, COPD, Cystic Fibrosis, etc.) and for inhalation toxicity testing of chemicals, while reducing the number of animal experiments. Human pulmonary toxicology, Preclinical Drug Development, and Human Tissue Reconstitution Type: SMB Activities: biotech deeptech Technologies: 3D Printing Synthetic Biology | 0 | 0 | 0 | 17 | |
Xeltis Transformative vascular implants. Addressing major life-threatening diseases, backed by Nobel-winning science. Xeltis is developing artificial vessels and valves that are gradually replaced by patients’ own living healthy tissue. www.xeltis.com Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology | 3 | 2 | 0 | 70 | |
VALANX Biotech Superpowering proteins. VALANX Biotech develops a proprietary technology for site-specific protein conjugation for applications in therapeutics, diagnostics and biocatalysis. Bioconjugation, Site-specific conjugation, PEGylation, Biotechnology, and Research and Development Tags: H2020 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 1 | 3 | 11 | |
BioNTech R&D (Austria) GmbH Subsidiary of BioNTech SE, now trading as BioNTech R&D (Austria). Developing novel anti-bacterials. BioNTech R&D Austria GmbH (formerly: PhagoMed Biopharma GmbH) is a fully owned subsidiary of BioNTech. The team in Vienna focuses on developing novel anti-bacterial drugs for persistent bacterial infections. Biotech Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 2 | 0 | 1 | 7 | |
Virtus Trading LLC (A Virtus Holding Company) Making the difference... VTL has a long proven experience in introducing cutting-edge healthcare equipment and solutions from world-class manufacturers. Their diverse capabilities in Marketing, Sales, Application Support and Service of a wide and comprehensive range of medical equipment and consumables for healthcare facilities, rehabilitation and wellness, makes them a leading solution provider in the region. Established in 2007 with offices in Abu Dhabi, Dubai and Al Ain, Virtus Trading LLC (VTL), from its humble beginnings, today employ more than 30 professionals who have contributed to the 75 Million AED revenue in 2014. VTL offers customers advanced medical management services, medical … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 44 | |
Orio Therapeutics At Orio Therapeutics, our mission is to save lives by making the regenerative medicine dream accessible and a wide-spread reality. We are dedicated to developing novel regenerative drugs with increased efficacy and reduced side-effects, using cutting-edge targeted drug-delivery technologies to create novel therapeutic proteins. Notably, we strive to demonstrate that efficient drug delivery technologies are not confined to the development of complex devices and drug carriers but can be achieved based on clever molecular designs. We aim to initially validate our program pipeline through the development of a therapeutic molecule for myocardial infarction that has the potential to change the … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 0 | 1 | |
Pelago Bioscience AB Pelago Bioscience Pelago Bioscience AB is founded to accelerate the use and value of the CETSA® technology in Drug Discovery and diagnostics. We know that the need for Target Engagement studies is large and increasing and there is no single technology with the same opportunities to fill this need as CETSA®. We will: - Make more relevant data available to our customers at an earlier stage of the Drug Discovery process - Enable filtering of compounds based on physiologically relevant data to facilitate better decisions in Drug Discovery programs - Provide our customers with CETSA® based Target Engagement data in … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 60 | |
Intervacc AB A new generation of vaccines based on fusions of recombinant proteins A new generation of vaccines within animal health We develop vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care, with a very good safety profile. Veterinary, Vaccines, Animal Health, Biotech, Recombinant Vaccines, Veterinary Products, Microbiology, Wholesale, and Research and Development Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 12 | |
IO Biotech Break Boundaries. Ignite Change. IO Biotech is a clinical-stage biopharmaceutical company pioneering the first-in-class investigational dual-action immune-modulating cancer vaccine with the goal of becoming the backbone of combination therapy for people with cancer. The Company’s T-win® vaccine platform is directed against the tumor microenvironment (TME) and is designed to stimulate T cells against tumor cells and the most important immune-suppressive cells in the TME. IO Biotech’s most advanced program for IO102-IO103 is currently in Phase 3 development. IO Biotech is headquartered in Copenhagen, Denmark. IO Biotech has achieved a proven track record of progressing compounds to the clinic, and has … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 90 | |
Merus N.V. Oncology company developing Biclonics® bispecific antibody therapeutics. See our Community Guidelines: http://bit.ly/36c Merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. Our most advanced development programs use the Biclonics® format. Biclonics® are capable of simultaneously attacking tumors in multiple ways. For example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways. Working at Merus offers opportunity to grow and develop a career that offers both individual and company success. You have the chance to make an impact within the oncology field by being part of the development of … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 257 | |
Mable Therapy Award-winning Speech Therapy and Counselling service for Schools, Colleges and Local Authorities. Mable has changed the way therapy is delivered in schools; streamlining communication between teacher, therapist and parents and delivering an evidence-based intervention that is not only functional but fun! We create memorable therapeutic experiences for pupils and all teaching staff. Speech and Language Therapy, Digital Health, Telepractice, Edtech, Education, Special Needs, Challenging Behaviour, SEMH, SEND, Speech Pathologist, Online Therapy, Children's Speech Therapy, Counselling, Psychotherapy, Wellbeing, Anxiety, Depression, Autism, Deafness, Developmental Langauge Disorder, Speech delay, and Teaching Type: Startup Activities: edtech kidtech Technologies: Synthetic Biology | 0 | 0 | 0 | 69 | |
Lightcast Profiling function, cell by cell. Lightcast is developing a novel, droplet-based platform that provides a deeper understanding of cellular function. Compared to standard microfluidic methods, the Lightcast platform offers the ability to run a broader range of assays and to precisely control and track the number, occupancy, location, and movement of each droplet. The unprecedented scalability and flexibility of this approach will help advance translational and basic research as well as streamline development workflows for drugs, therapeutics, and applied biologics. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 111 | |
Bactolife Enhancing global health through scientific food ingredients that fortify the gut microbiome We are on a mission to enhance global gut health and support the fight against antimicrobial resistance. As a Danish biotech firm, we are pioneering the future of gut health with our unique food ingredient, Binding Proteins. Binding Proteins are natural and versatile enough for any food, beverage, or supplement, selectively bind and block harmful microbial activity without disturbing the beneficial microbiome. Our food ingredients are specially formulated for diverse needs, benefiting everyone from mothers and children to the elderly, immune-compromised individuals, travelers, and even animals. Backed by … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 3 | 1 | 2 | 59 | |
Bitome Better tools, faster science Bitome is a Boston-based life sciences tools company that uses metabolomic insights to drive efficient biomanufacturing. Bitome's magnetic-resonance/neural-network-driven platform provides quantified analysis of the cell culture environment -- enabling bio-based products to get to market faster. Our mission at Bitome is to enable the bioeconomy with purpose made tools, so join us as we de-risk industrial biology. Magnetic Resonance, synthetic biology, continuous monitoring, metabolic analysis, lab automation, instrumentation, MEMS, microfluidics, and machine learning Type: Startup Activities: deeptech biotech Technologies: A.I. A.I. - Machine Learning Bio sourced materials Synthetic Biology | 0 | 0 | 0 | 1 | |
ProsFit Our Vision: A world where innovation provides limb wearers a choice of affordable, reliable and desirable prosthetic products and services. Motivation: We aim to play our part in enabling confident mobility, timely rehabilitation, community inclusion, and social integration. Through smart deployment of crucial innovation we want to help build transparent health economics, and attract new talent into the industry. Business model: Supports prosthetic clinic owners to radically improve productivity and user outcomes. Innovation roadmap for transformation of prosthetic service delivery at a global scale. Implementation through scalable business model, sized to fit 20m amputees globally. PandoFit: Proprietary cloud-based cross-platform, modular … Type: Startup Activities: healthtech deeptech Technologies: 3D Printing Synthetic Biology | 1 | 1 | 0 | 8 | |
NanoGenics Nanogenics is an innovative, research-based biotechnology company that specialises in developing bespoke, peptide-based vectors for gene therapy. Nanogenics is proud to introduce LipTideTM; an exciting custom-built delivery vehicle that can be modified to target different cell types and deliver different payloads for all gene therapy. LipTideTM is a peptide nanoparticle that has already shown excellent in vivo efficacy across a range of models and delivery routes, including nebulised and systemic administration. The peptide component performs two functions: it binds the payload to form the core of the nanoparticle and it also triggers receptors on target cells, which cause the cell … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 1 | |
Fited Omurga Sağlığınız Önceliğimiz. Kişiye Özel Tasarım 3D Korseniz bir haftada hazır. Ücretsiz ön değerlendirme>05426577406 Fited makes patient-specific 3D printed braces. custom-fit, 3d Printed, medical device, medtech, and healthcare Type: Startup Activities: healthtech deeptech Technologies: 3D Printing Synthetic Biology | 3 | 0 | 3 | 8 | |
Biotherm Biotherm is a medical devices company based out of 2163 Glendale Galleria, Glendale, California, United States. Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 5 | 2 | 1 | 65 | |
SEHA Corniche Hospital SEHA Corniche Hospital has a legacy as the most-trusted and leading referral center for Women and Newborn care in Abu Dhabi, with more than 46 years of dedication to motherhood and over 300,000 babies delivered till date. Envisioned by H.H. Sheikha Fatima bint Mubarak, SEHA Corniche Hospital offers a comprehensive range of advanced obstetrics, gynecology, and neonatology services, with subspecialty care services and clinics dealing with fetal medicine, infertility, obstetric medicine, aesthetic gynecology, pain management and allied health disciplines, including lactation and physiotherapy. SEHA Corniche Hospital has a US accreditation as Centre of Excellence for minimally-invasive surgery and endometriosis care, … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 3 | 2 | 0 | 591 | |
Precision BioSciences, Inc. Dedicated to Improving Life. Precision BioSciences, Inc. (Nasdaq: DTIL) is a pre-clinical stage gene editing company developing in vivo gene editing with its highly precise and versatile ARCUS genome editing platform. ARCUS uses sequence-specific DNA-cutting enzymes, or nucleases designed for gene knock out, as well as highly complex edits for gene insertion and/or gene repair. Precision BioSciences is based in Durham, North Carolina. For more information about Precision BioSciences please visit www.precisionbiosciences.com. Gene Editing and Gene Therapy Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 1 | 1 | 124 | |
Nesa Medtech NESA MEDTECH PRIVATE LIMITED is a medical device startup working towards excellence in the Research & Development of Medical devices for emerging countries specifically India, and believes in pursuing business through innovation and technology. This is focused on delivering minimally invasive therapeutic devices innovation to address social and economic burden. NESA MEDTECH is mentored and supported by Department of Biotechnology, Government of India and Karnataka Biotechnology and information technology services. Type: Incubators & VCs Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 2 | 0 | 2 | 18 | |
Solar Foods We are introducing a game-changing natural protein for the global food industry. #NextGenEU #NextGenerationEU Solein is a game-changing protein for the global food industry. Produced from air – CO2, water, nitrogen – and electricity, our unique natural single-cell proteins are not dependent on agriculture, weather or the climate. Creating the future of sustainable food with an unlimited diversity of proteins. #NextGenEU #NextGenerationEU Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 19 | 5 | 12 | 56 | |
Theseus Pharmaceuticals Theseus is developing best-in-class kinase inhibitors to shape the future of targeted oncology. Theseus Pharmaceuticals is passionately committed to outsmarting cancer resistance. Cancer is constantly mutating, allowing it to evade initially effective oncology treatments. Theseus believes we can predict how cancer will change, enabling new therapies to stay ahead of future mutations and overcome the demonstrated burden of treatment resistance. Led by a team of pioneers in the discovery and development of tyrosine kinase inhibitors (TKIs), we are developing best-in-class, pan-variant kinase inhibitors, to shape the future of targeted oncology. PLEASE NOTE: All open positions for Theseus Pharmaceuticals will be … Type: Startup Activities: it services Technologies: A.I. Synthetic Biology | 0 | 0 | 0 | 31 | |
UrSure, Inc. UrSure makes patient-friendly diagnostic tests that measure and improve adherence to medications. UrSure makes urine tests to help doctors and patients improve medication adherence. We are initially focused on drugs to prevent and treat HIV infections. We have received over $2M in funding including winning the Harvard Business School's New Venture Competition and the Harvard President's Innovation Challenge as well as a Phase I and II SBIR from the NIH. We are currently working to scale up our lab based test, which is commercialized and on the market while we complete development of our Point of Care test which will … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 2 | 0 | 1 | 1 | |
LA MER Our journey began when Dr. Max Huber suffered burns in a lab accident and was inspired to create his own destiny. Aerospace Physicist by day, star-gazer and dreamer by night, he hoped to unlock the legendary healing powers of the sea he held so dear. 6,000 experiments and 12 years of searching led to the epiphany of a lifetime – a fermentation process that transformed sea kelp and other pure ingredients into Miracle BrothTM. This cell-renewing elixir at the heart of Crème de la Mer would finally transform the look of his skin. For more LA MER, visit... https://www.cremedelamer.com/ https://www.instagram.com/lamer … Type: Startup Activities: cosmetics deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 331 | |
Grillido GmbH [Automatic translation follows] Enjoyment with a clear conscience and strong nutritional values. At Grillido, we place particular emphasis on high-quality raw materials and a balanced nutritional profile for our products. We are proud to enable enjoyment without sacrifice, be it through our delicious sausages for meat lovers, protein-rich grilled cheese for cheese fans or a wide range of veggie alternatives. Our goal is to promote a healthier future and to inspire customers with the best taste experiences. We focus on quality and innovation. Type: Startup Activities: foodtech Technologies: Synthetic Biology | 0 | 0 | 0 | 15 | |
LenioBio Rapid eukaryotic, cell-free protein expression that scales for research, development and production. At LenioBio, we develop efficient, robust and sustainable technologies to disrupt the way medicines and food are produced for those in need, wherever they are. Unconstrained by the limitations of cells, we combine our proprietary protein technology with machine learning to significantly accelerate innovation cycles in life science industry. Protein Expression, Protein Production, Synthetic Biology, Biotechnology, Membrane proteins, Antibodies, Functional Proteins, Sustainable Foods, Vaccines, Therapeutic Proteins, Structural Biology, Cell-free protein production, Cell-free protein expression, and Plant-based protein Type: Startup Activities: biotech deeptech manufacturing Technologies: A.I. A.I. - Machine Learning Bio sourced materials Synthetic Biology | 7 | 1 | 6 | 51 | |
64x Bio An evolution in cell line engineering. High throughput engineering of cell lines to enhance the design and manufacture of next-generation therapeutics. Gene therapy, Synthetic Biology, Genome Engineering, and Functional Genomics Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 1 | 0 | 23 | |
Epiminder Epiminder is a medical device company developing the next generation brain monitoring technology. The company’s first product, the MinderTM system, is an implantable EEG monitoring system designed to detect epileptic seizures. Through long term and continuous EEG measurements, the system will provide unparalleled insights into brain activity, significantly improving the diagnosis and management of epilepsy and helping people with epilepsy take back control of their lives. Epilepsy is complex neurological condition which affects over 80 million people worldwide, 30% of whom don’t respond to medication. The MinderTM system consists of a small implant placed just under the scalp, a multi-channel … Type: Startup Activities: deeptech healthtech Technologies: A.I. Synthetic Biology | 0 | 0 | 0 | 26 | |
Neogene Therapeutics Pushing the frontier by pioneering next-generation engineered T cell receptor therapies for solid cancers Neogene Therapeutics is a global, clinical-stage biotechnology company pioneering the discovery, development, and manufacturing of next-generation engineered T cell receptor (TCR) therapies targeting a broad spectrum of solid cancers. With offices in Santa Monica, CA and Amsterdam, the Netherlands, Neogene is aiming to change the paradigm of treatment for solid cancers. Neogene is a member of the AstraZeneca Group. Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 1 | 0 | 1 | 188 | |
XING Technologies XING Technologies has a clear vision in applying diagnostic nanotechnologies to globally enhance healthcare systems. We are an Australian-owned and operated cancer pathology lab that uses genetic sequencing to inform doctors and patients about precision cancer treatment options. Precision medicine offers cancer patients therapy options that are targeted specifically to their cancer. XING Genomic Services offers a range of cancer genetic tests for both newly diagnosed cancer patients and patients dealing with a recurrence of their disease. The results analysed in our lab will determine whether the genetic alterations found in your cancer match genetic changes that are associated with … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 3 | |
PrimeCell Advanced Therapy, a.s. [Automatic translation follows] PrimeCell Therapeutics is a Czech biotechnological company focused on the field of regenerative medicine and modern therapy, whose goal is to develop and manufacture Advanced Therapies Medicinal Products that improve people's quality of life. The company PrimeCell Therapeutics was founded in 2007 with the aim of building globally competitive hi-tech centers in the Czech Republic, which will be involved in the global process of development of modern cell therapy. PrimeCell Therapeutics enables doctors and patients with new treatment methods that use human cells and new materials, such as nanomaterials, to treat serious diseases. Thanks to its unique … Type: Startup Activities: deeptech manufacturing Technologies: New Materials Synthetic Biology | 0 | 0 | 0 | 16 | |
Starlab We believe in progress through science. Our solutions enable bright minds to change the world. We believe in progress through science. Our solutions enable bright minds to change the world. We are “Passionate for Science”. Since 1998. Our product portfolio specializes in the field of Liquid Handling Technology and laboratory products. Our product portfolio includes laboratory consumables such as pipette tips, single and multi-channel pipettes, cell culture, tubes, PCR consumables, nitrile and latex gloves, and benchtop equipment for general laboratory use. Our products and services are in daily use at research institutions in biological and medical institutes, universities and hospitals, … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 1 | 0 | 296 | |
Sopharma We have an active and crucial role in raising standards of everyday life, in making people healthier, happier and safer. Sopharma PLC is one of the leading pharmaceuticals company in Bulgaria popular with manufacturing of high-quality medicines, modern businessethic and social responsibility. The highly technological process for development and production of our products is licensed according to the GPP - Good Production Practices. Type: SMB Activities: deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 617 | |
TB TB is an internet company. Type: Startup Activities: healthtech Technologies: Synthetic Biology | 6 | 2 | 1 | 652 | |
Spectroplast AG Breaking boundaries by leading the industrial revolution in unprecedented elastomer solutions Spectroplast is an On-Demand Service Provider for end-use silicone products that are functional and perform. What many industries have tried for years, Spectroplast has achieved with Silicone Additive Manufacturing, making silicones accessible to Industry 4.0. For the first time, end-use silicone products are directly fabricated without the use of molds, saving costs, time while offering an unprecedented freedom of design: - Shore Hardness A20, A35, A50 and A60 - Highest precision 3D Printing, Silicone, Silicone 3D Printing, Soft materials, High precision 3D printing, Additive Manufacturing, Medical, Manufacturing, Technical, Healthcare, … Type: Startup Activities: industry 4.0 manufacturing Technologies: 3D Printing Synthetic Biology | 3 | 0 | 1 | 12 | |
German Bionic We got your back – Smart tools for the future of human physical work. German Bionic is a European robotics firm that develops and manufactures smart power suits and other wearable technologies. It was the world’s first company to deliver connected exoskeletons for the workplace, applying self-learning and artificial intelligence to support lifting movements and prevent poor posture, and thereby becoming an intelligent link between humans and machines. The German Bionic smart power suits and wearables protect the health of workers and markedly reduce the risk of accidents and injury to consequently improve work processes. In recognition of this innovative … Type: Startup Activities: it services manufacturing Technologies: Robotics Synthetic Biology | 12 | 2 | 11 | 77 | |
Enovis We are a medical technology company focused on developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, extraordinary talent and innovation, we ‘create better together’ by partnering with healthcare professionals. Our extensive range of products, services and integrated technologies fuel active lifestyles. orthopedics and animal health Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 2 | 1 | 1 | 3,045 | |
Comphya Providing a better solution for non-responders to oral drugs. Comphya is a Swiss medical device company, spin-off from the Swiss Federal Institute of Technology (EPFL). Its mission is to overcome the major clinical problems of erectile dysfunction (ED) in spinal cord injury and post-prostatectomy patients (non-responders to oral drugs). Our innovation lies on neuroprosthetics principles and will offer a unique and superior treatment for ED. Our goal is to fulfill patient needs through safe and effective medical devices, offering life quality in large parts of the male population in great need. Urology, Medical Devices, Neuroprosthetics, and Erectile Dysfunction Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 1 | 0 | 9 | |
Aseptuva Aseptuva is a Swiss-UK Medtech startup, with offices in Bern, Zurich & Cambridge, working to prevent hospital infections We are developing a series of medical devices in the Class II (a,b) category, for in-situ disinfection of catheters and tubes inserted into patients inside an ICU environment, as well as on the outside. Our automated and targeted solution strives to prevent secondary infections in hospitals such as VAP, CLABSI etc, thereby reducing the burden on healthcare workers, and improving the overall patient experience by shortening hospital stay and saving additional costs. Type: Startup Activities: healthtech Technologies: Synthetic Biology | 5 | 2 | 4 | 7 | |
INCAPTEK Swiss start-up developing advanced drug delivery systems for biotech/medtech and high-performance materials. INCAPTEK Sàrl is a start-up from Switzerland developing advanced drug delivery systems and technologies to produce high-performance materials. We design smart micro(nano)encapsulation solutions and highly innovative materials for controlled and targeted drug delivery for biotech and medtech industries. We deliver drugs at the right place, in the right dosage, and at the right time, bringing treatment outcomes to the next level. Our technologies can be used as a standalone drug delivery platform for pharmaceuticals and genetic material, as well as for drug-eluting coatings for implantable medical devices and … Type: Startup Activities: deeptech nanotech Technologies: Synthetic Biology New Materials | 0 | 0 | 0 | 2 | |
Medyria Smooth and effective cardiovascular procedures Medyria is a Swiss medtech company that engineers technologies for endovascular catheter navigation and sensing. Medyria objective is to make catheter based procedures faster, safer and more effective. Medyria is based In Technopark, Winterthur., Switzerland Medical Devices, EVAR , Technopark Winterthur, and Swiss Startups Type: Startup Activities: healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 12 | |
VitroLabs Inc Harnessing science and nature to cultivate authentic materials starting with slaughter-free cultivated leather. We cultivate authentic materials without compromise,by harnessing science and nature responsibly by partnering the most innovative minds in science and technology with the finest craftspeople to accelerate the use of cellular agriculture for good. Our first product is slaughter-free, real leather. cellular agriculture, tissue engineering, leather, luxury leather, lab-grown, cultivation, Bioprocessing, and bioreactor Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 2 | 1 | 23 | |
CardioSignal by Precordior CardioSignal is developing a disruptive mobile application-based technology to improve the detection of heart disease. CardioSignal is a health technology company developing groundbreaking solutions for early detection of heart diseases. We are based in Turku, Finland and Palo Alto, CA, United States. The CardioSignal mobile application is a CE-marked class IIa medical device for the detection of atrial fibrillation, available in over 10 countries. The technology we are developing enables a digital cardiac biomarker for other major heart diseases as well. CardioSignal is a brand and a product by Precordior. Originally an academic spinoff, the company’s patented motion sensor technology … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 1 | 0 | 1 | 31 | |
FreeOx Biotech Freeox Biotech is an innovative late-stage clinical company singularly focused on the discovery and development of Cerebrovascular Protective Therapeutics. A Phase III-ready investigational drug – Ox-01, the company’s lead asset – has been shown to be an effective emergency adjunct therapy to Mechanical Thrombectomy for the treatment of Acute Ischemic Stroke (AIS). Stroke, Oxidative stress, Neuroprotective therapies, Health research, Biotechnology, and Clinical research Type: Startup Activities: deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 3 | |
Asahi Kasei Bioprocess America, Inc. Pioneering Biologics Safety and Manufacturing Efficiency As a global partner to the biopharmaceutical industry, Asahi Kasei Bioprocess helps biologics manufacturers safely and efficiently produce medicines that patients can trust, by dependably supplying innovative yet exceptionally reliable bioprocess consumables, equipment and scientific support services. Our portfolio is anchored by PlanovaTM virus removal filters. First released in 1989 as the world's first hollow fiber filter developed specifically for removing viruses from biotherapeutic drug products, PlanovaTM filters ensure viral safety of biopharmaceutical drug products, thanks to their high quality and consistent performance. Leveraging 30 years of experience, we continue to provide our customers … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 123 | |
Maze Therapeutics At Maze, we envision a world where genetic insights inspire new medicines. Maze Therapeutics is translating novel genetic insights into lifesaving medicines, through an approach that integrates human genetics and functional genomics. Advances in these areas have enabled us to decode the mysteries of genetic modifiers in a range of severe diseases, which we aim to turn into medicines that mimic protective mutations. We have assembled a world-class team that we need to realize this vision, including creative scientific pioneers in genetics, experienced company builders, and biotech industry leaders. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 0 | 1 | 127 | |
Tetra Therapeutics Restoring Clarity of Thought Tetra Therapeutics is clinical stage biotechnology company developing medicines for Alzheimer's Disease, Fragile X syndrome, Traumatic Brain Injury, major depression and schizophrenia. The drugs in our pipeline offer a new mechanism focused on PDE4B and PDE4D. Tetra designs drugs to treat memory loss and cognitive impairment by improving how the brain processes and stores information. Tetra's promising drug for Alzheimer's Disease, BPN-14770, is being developed in partnership with the NIH Blueprint Therapeutics program. Our PDE4B platform addresses neuroinflammation, progressive multiple sclerosis (MS), and chronic traumatic encephalopathy (CTE). drug discovery, Alzheimer's Disease, schizophrenia, PDE4D, PDE4B, Fragile X, … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 7 | |
Qpex Biopharma Focusing on Resistance in Antibiotic Development Qpex Biopharma, Inc. a Shionogi Group Company, is a resistance-focused infectious disease company on a mission to make both a dramatic and sustainable improvement in patient care. Leveraging a multi-faceted approach and a deep understanding of drug resistance mechanisms, we are creating novel products and development. strategies that overcome multi-drug resistance. We are advancing a robust portfolio of treatments that will bring innovation to antibiotic development and deliver the right treatments to the right patients in the right settings. During the previous decade, our team brought 4 antibiotic products to regulatory approvals, with an … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 1 | 1 | 24 | |
Kelonia Therapeutics Revolutionizing in vivo gene delivery to usher in a new era of genetic medicines. Kelonia is pioneering a new wave of genetic medicines using its next generation gene delivery platform. The company’s simple and elegant cutting-edge in vivo gene delivery technology uses a few potent lentiviral vector-like particles to precisely and efficiently deliver in vivo genetic cargo to the desired target tissue, and only that tissue, every time. With an initial focus on developing transformational therapies for solid tumors and hematologic cancers, Kelonia is building a pipeline of genetic medicines for a wide range of diseases, with the bold goal … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 1 | 1 | 59 | |
CellSine Discover your favorite frequencies to boost your drug discovery business CellSine provides devices and software that make advanced electrochemical impedance spectroscopy easily accessible to any microbiological researcher. It delivers a platform tool for a that enables a wide variety of biochemical studies. Biotechnology, Cell culture monitoring, Proteïn - Proteïn interactions, Suspension cultures, Receptor signaling, Biofilm maturation, and T lymphocyte activation Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 4 | |
VetStem, Inc. Leading the way in Regenerative Veterinary Medicine Since its formation in 2002, VetStem has endeavored to improve the lives of animals through regenerative medicine. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, VetStem pioneered the use of regenerative stem cells in veterinary medicine; VetStem holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In January of 2004 the first horse was treated with VetStem Regenerative Cell Therapy for a tendon injury that would normally have been career ending. By … Type: SMB Activities: pettech biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 23 | |
Galmed Pharmaceuticals Ltd. A clinical-stage drug development biopharmaceutical company for liver, metabolic & inflammatory diseases Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Our lead compound, AramcholTM, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study. We are also collaborating with the Hebrew University in the development of Amilo-5MER, a 5 amino acid synthetic peptide. Our corporate headquarters is located in Tel Aviv, Israel. For more information about Galmed, please visit our website at: www.galmedpharma.com Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 11 | |
Arete Medical Technologies Our mission is to improve patient outcomes and healthcare efficiency, starting with chronic respiratory conditions. Chronic respiratory diseases reduce the quality of life of millions worldwide, and are a major cause of death. Health systems are increasingly strained. We believe improved care in the future can only come from more preventative and precision care. We apply advances in digital technologies and medical devices to both improve care and health system efficiency. Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 5 | 1 | 3 | 3 | |
Bionova Scientific CDMO Services (Research, Development and cGMP Manufacturing for Biologics) Bionova Scientific is a dynamic, full service, biologics Contract Development and Manufacturing Organization (CDMO) on a mission to deliver the highest quality process development and manufacturing services to biologic drug development companies around the world. Bionova’s renowned scientific expertise and dedication to its customers helps life changing therapies arrive to the market faster and more efficiently. At the heart of Bionova is a team of highly dedicated experts combining strong experience in cGMP biologics manufacturing and process development, with a technology-focused approach and a deep knowledge of the industry. From early … Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 1 | 0 | 1 | 92 | |
FRAXA Research Foundation FRAXA’s mission is to find effective treatments and ultimately a cure for Fragile X syndrome. FRAXA Research Foundation is a national 501c3 nonprofit organization. FRAXA’s mission is to find effective treatments and ultimately a cure for Fragile X syndrome. We directly fund research grants and fellowships at top universities around the world. We partner with biomedical and pharmaceutical companies, large and small, to bridge the gap between research discoveries and actual treatments. Treatments for Fragile X are likely to help people affected by autism, Alzheimer’s, and other brain disorders. FRAXA also supports families affected by Fragile X syndrome and raises … Type: SMB Activities: deeptech Technologies: Synthetic Biology | 1 | 1 | 1 | 13 | |
OTSUKA PHARMACEUTICAL S.A. [Automatic translation follows] Otsuka Pharmaceutical is a global healthcare company with a guiding motto: “Otsuka – people creating products for better health in the world.” At Otsuka we research, develop, manufacture and market innovative products to address unmet medical needs and nutraceutical products for the maintenance of daily health. We focus our efforts primarily on the area of Mental Health and Nephrology, as well as having research programs in several under-addressed diseases, including oncohematological pathologies or multi-resistant tuberculosis, a major challenge for global public health. Otsuka is made up of 34,400 people in 32 countries around the world, 168 companies, … Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 166 | |
Otsuka Medical Devices Co., Ltd. Since its establishment in February 2011, Otsuka Medical Devices Co., Ltd. has focused on developing unique solutions that improve the health and well-being of patients whose medical needs and conditions cannot yet be fulfilled by existing treatment methods. To achieve our aspiration of becoming a pioneer in the medical device industry, we combine global R&D efforts with the technology and drug discovery know-how inherent within the Otsuka group’s heritage. Type: SMB Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology | 1 | 1 | 0 | 26 | |
中外製薬工業 / Chugai Pharma Manufacturing Co., Ltd. [Automatic translation follows] INNOVATION BEYOND IMAGINATION Within the Chugai Pharmaceutical Group, Chugai Pharmaceutical Industries is responsible for development and production. We receive manufacturing processes for investigational drugs and products from Chugai Pharmaceutical, create methods and systems for actual production in the factory, and carry out the associated quality control and evaluation. In this way, we play an essential role in turning pharmaceutical ideas into real products that are useful to patients. Pharmaceuticals, new drug development, global companies, biopharmaceuticals, small and medium molecule drugs, pharmaceutical manufacturing, production technology, IT engineers, engineers, quality control, and quality assurance Type: SMB Activities: it services Technologies: Synthetic Biology | 0 | 0 | 0 | 71 | |
Integrated Micro-Chromatography Systems A leader in recombinant enzymes and automated micro-chromatography technologies About Integrated Micro-Chromatography Systems, Inc. At Integrated Micro-Chromatography Systems (IMCS), we strive to address the growing needs of clinical and research laboratories through advanced technologies that increase testing efficiency. IMCS products help to drive the future of precision medicine. We understand the importance of accuracy, which is why we are committed to delivering products that consistently provide fast, reliable results. Company History Integrated Micro-Chromatography Systems, Inc (IMCS) was founded in January 2013 by three scientists from the University of South Carolina. IMCS designs, develops, manufactures, and distributes next-generation recombinant proteins and … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 1 | 0 | 1 | 34 | |
SynTouch, Inc. We bring scientific certainty to decisions about product feel CREATING PRODUCTS THAT HUMANS PREFER TO TOUCH The SynTouch Toccare® Haptics Measurement System uses mathematical models based on proven haptics science to guide the design and manufacturing of products and materials that feel how humans prefer them to feel. The industries we serve include nonwoven fabrics and products, apparel, textiles, automotive, cosmetics, and consumer electronics. Everything the human finger can sense, the Toccare system can precisely and repeatedly quantify biomimetically. Designers and manufacturers use Toccare touch data to compare, test, communicate and optimize with both subtlety and accuracy the feel of … Type: Startup Activities: deeptech manufacturing Technologies: Sensors Robotics Synthetic Biology VR | 0 | 0 | 0 | 10 | |
Ossium Health The Greatest Wealth is Health® Our mission is to improve the health, vitality, and longevity of human beings through bioengineering. Who we are: At Ossium, we believe that science is humanity’s best weapon in the fight against disease, and we embrace the challenge of mobilizing the world’s healthcare ecosystem to win that fight. In pursuit of this goal, we empower our employees, maintain the highest standards of excellence, and are a force for good. Values we live by: Impact We are mission-driven and results-oriented. We believe that a healthier world is a better one and that our work should drive … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology Data Analytics | 2 | 0 | 2 | 90 | |
Koatum An innovative solution for medical implants Koatum is a MedTech startup that developed a medical implant coating technology for dental and orthopaedic implants. Koatum prevents inflammation and accelerates bone integration, for a faster, painless recovery. Technology provides opportunity to coat any materials which could not be coated with plasma sputtering due to the high temperatures involved. An inert first layer is ensuring perfect formation between implant and coating. Upper layers, made from hydroxyapatite without the intense heat used in plasma coating, remain bioactive and durable. Technology also provides the ability to implement drug delivery systems. With Koatum technology surgeon can … Type: Startup Activities: it services Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
Cyclica (acquired by Recursion, Nasdaq: RXRX) From molecule to medicine Unlocking the protein universe to discover the medicines of tomorrow Cyclica has been acquired by Recursion! Please follow @Recursion on LinkedIn and @RecursionPharma on Twitter to receive updates on our next chapter. Drug Development, Network Pharmacology, Drug Repositioning, Proteomics, Clinical Trials, Side Effects, Bioinformatics, Systems Biology, Drug Discovery, Artificial Intelligence, polypharmacology, medicines, Machine learning, pharmacology, pharmaceuticals, and bioinformatics Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology A.I. A.I. - Machine Learning | 20 | 3 | 13 | 4 | |
PDC*line Pharma A novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell line (PDC*line) Founded in 2014 as a spin-off of the French Blood Bank (EFS), PDC*line Pharma is a French-Belgian biotech company that develops an innovative class of active immunotherapies to treat cancers. This cancer vaccine contains proprietary, potent, and scalable plasmacytoid dendritic cell line (PDC*line), whose remarkable characteristics make them excellently suited for immunotherapy. PDC*line is much more potent to prime and boost antitumor antigen, including neoantigens, specific cytotoxic T-cells than conventional vaccines and improves the response to checkpoint inhibitors. PDC*line offers unique advantages: - PDC*line … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 13 | 3 | 7 | 26 | |
BioNTech SE Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases. BioNTech is a global next generation immunotherapy company aspiring to translate science into survival. Around 6.100 pioneers currently work with us, employing a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Our broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor (CAR) T cells, several protein-based therapeutics, including bispecific immune checkpoint modulators, targeted cancer antibodies and antibody-drug conjugate (ADC) therapeutics, as well as small molecules. … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 41 | 19 | 9 | 4,777 | |
Creativ-Ceutical Creativ-Ceutical provides strategic pricing, market access and health economics consulting in life sciences. We provide both the strategic advice and the technical services to deliver results that meet your expectations. We have broad experience in the areas of central nervous system (CNS), oncology, vaccines, metabolic/cardiovascular diseases, and rare diseases. These are complex and developing fields, where treatment paradigms are in constant evolution and where clinical and economic issues require rigorous analysis to determine the best therapeutic choices. This experience allows us to address the most complex challenges and to anticipate pricing and market access issues that will arise in other … Type: SMB Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 83 | |
Venn Life Sciences - part of hVIVO plc Integrated Drug Development from Discovery to Market - Part of the hVIVO plc Venn Life Sciences - part of hVIVO plc is an Integrated Drug Development partner offering an unique combination of drug development consultancy, clinical trial design and execution, enabling us to create, plan and execute drug development programmes effectively for our customers. Venn’s capabilities and expertise includes: CMC, Non-Clinical, Clinical Development and Regulatory Affairs. With our independent position we can design an optimal program including risk assessment and mitigation, saving time and money whilst achieving project milestone objectives. Visit our website - www.vennlifesciences.com for more information. Drug Substance … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 1 | 2 | 113 | |
Wave Life Sciences Unlocking the broad potential of RNA medicines to transform human health Wave Life Sciences is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Our RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Our toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing us with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. Our diversified pipeline includes clinical programs in Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency … Type: Startup Activities: deeptech Technologies: Synthetic Biology | 7 | 4 | 4 | 335 | |
Roka Furadada Smart active ingredients, safer sun exposure Catalonia Exponential Leader 2023 Roka Furadada’s mission is to reduce the incidence of skin cancer through research, development and production of active ingredients and medical devices, with high efficiency and low toxicologic and environmental impact OUR PURPOSE Roka Furadada wants to help to prevent and reduce the incidence of skin cancer. HOW ARE WE GOING TO DO IT? Developing the first intelligent ultra violet radiation filter: SMART UV, with new molecules that entail therapeutic activity to prevent and treat diseases associated with sun exposure. Cosmetics, Raw Materials , Ingredients, Cosmetic Ingredients, Sunscreen, Sun protection … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 1 | 5 | 24 | |
Tinnitracks Tinnitracks is a medical devices company based out of 30 Neuer Kamp, Hamburg-Sternschanze, Germany. Type: Startup Activities: healthtech Technologies: Synthetic Biology | 6 | 1 | 2 | N/A | |
Five Alarm Bio Limited Boosting the body's ability to defend against the damage of aging Five Alarm Bio is a drug discovery company based in Cambridge, UK focusing on novel approaches to anti-aging, with broad potential therapeutic application. We are researching therapeutics that boost the body's ability to defend against the damage of aging. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 4 | |
Paleo Rewriting the story of meat. At Paleo, we are rewriting the story of meat. First, we hunted. Then, we bred. Now, we brew. We brew the crucial meat ingredient that makes plant-based products look, taste and act more like the real deal. By helping manufacturers in convincing consumers, we accelerate the #ProteinShift. Because we care. We care for the animals, for our next generations and for providing nutritious foods. We care for the planet and the legacy that we’ll pass on. That's why, to produce our animal heme proteins, we no longer use animals. Instead, we use yeast. At Paleo, … Type: Startup Activities: foodtech Technologies: Synthetic Biology | 7 | 3 | 5 | 51 | |
Tân-Tân Foods [Automatic translation follows] The healthy and nutritious plant-based alternative Tân-Tân is a startup that advocates for a healthier and more plant-based food transition, through a range of medallions rich in protein and easy to cook. vegetarian, vegan, protein, and food transition Type: Startup Activities: foodtech Technologies: Synthetic Biology | 2 | 1 | 0 | 2 | |
Robo Bionics A Hand for a Missing Hand with the Sense of Touch | National Startup Award 2021 | CSR Partnerships | Social Impact Robo Bionics has developed Grippy India’s Own NABL Lab Safety Tested and Certified, 3D printed Prosthetic hand with a sense of touch and multi-grip control. Designed, engineered, and proudly made in India, Grippy is a lightweight and affordable, battery-powered prosthesis now available in the Indian market for people with below elbow amputation age 15 years and above. Welcome to the future where we have made Bionics as simple as switching on a light bulb. Robo Bionics a Recognized … Type: Startup Activities: deeptech Technologies: 3D Printing Batteries Robotics Synthetic Biology | 6 | 0 | 6 | 5 | |
Eurofins Discovery Eurofins Discovery offers you a complete, single-source solution for drug discovery products and services. Eurofins Discovery has supported Drug Discovery research for >40 years. Our partners inspire us to innovate in the pursuit of life-changing cures. We provide our experience, depth, and breadth in the form of innovative testing services and product tools that support researchers as they accelerate the discovery and development of candidate molecules. Our global team of dedicated scientists, information analysts, and client support professionals make this mission possible. Our focus drives us to continually expand our portfolio of testing methods, tools, and services to enable real, … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 2 | 0 | 212 | |
NanoSpun Technologies We harness the power of biology to create revolutionary live-active cell-based products and solutions. NanoSpun is a global pioneer and frontrunner in the biotech, advanced materials and bioprinting spaces. We are leading the way to a whole new generation of cell-based products and solutions through the intelligent application of NanoSpun biological fabrics. No other company can do what we do. We encapsulate live and active biological cells and organisms, including bacteria, yeast, algae, plant cells, and mammalian to produce living tissues and fabrics with a wide application across many industries. Our current market focus is to revolutionize Skincare and Bioprocessing. … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 9 | |
Vytrus Biotech Natural Innovation for a Better Life. Applying the real power of plants to cosmetics through biotechnology We create natural active ingredients for skincare and haircare through innovative and sustainable biotechnology processes which obtain the real power of plants. Totipotent Cells Type: Startup Activities: deeptech cosmetics biotech Technologies: Bio sourced materials Synthetic Biology | 1 | 0 | 1 | 37 | |
Limula Cell & Gene Therapy: Automated. Scalable. Accessible Limula provides an innovative solution for the production of the most personalised cancer treatments on demand and at scale. Our product is a unique proprietary platform can perform multiple steps of cell therapy manufacturing in a single device, using end-to-end automation and integrated process analytics. Bioproduction, Immunooncology, Cell therapy, Biotechnolgoy, Manufacturing, and CAR-T Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 1 | 2 | 20 | |
FIRE1 Our purpose is to help millions of people living with heart failure to get their normal back. FIRE1 aims to improve patient quality of life, and patient outcomes, while lowering overall healthcare costs. Health Tech, Research & Development, Medical Devices, Software Engineering, and Clinical Type: Startup Activities: deeptech Technologies: Synthetic Biology | 2 | 2 | 0 | 62 | |
CompagOs Transforming drug development and personalized medicine with Bon3OIDTM in vitro models CompagOs, a Swiss spin-off from ETH Zürich, is revolutionizing bone health by empowering researchers to develop breakthrough therapies and supporting doctors in matching the right patients with the right treatments. Utilizing cutting-edge 3D bioprinting technology, we create biologically relevant and reproducible organotypic human Bon3OIDTM in vitro bone models. We offer services on these models for basic research, drug efficacy, and toxicity testing, focusing on bone biology, rare bone diseases, inflammatory bone disorders, and bone oncology. 3D bioprinting, rare bone diseases, bone oncology, bone biology, drug efficacy, and drug toxicity Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 4 | |
Causeway Therapeutics Healthy Ageing Through Musculoskeletal Health Maintaining musculoskeletal health is the keystone of overall health as we get older. As we age our physical condition gradually deteriorates, leading to loss of strength, fitness and mobility. In most cases, this isn’t due to a simple decision to stop exercising. It is due to the breakdown of musculoskeletal function caused by disease. Musculoskeletal diseases such as osteoarthritis, tendinopathy and lower back pain are the primary causes of disability and early retirement in people over the age of 65. Currently, there are no approved disease-modifying drugs for these diseases, meaning that physical decline in … Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 2 | 0 | 1 | 6 | |
ToxGenSolutions BV (TGS) Epigenetics-based diagnostics, prognostics and preventative therapeutics for high-impact chronic pathologies. ToxGenSolutions (TGS) applies toxicogenomic approaches on human health problems to provide the customer with epigenetic biomarker fingerprints for application in novel, more accurate, methods for the particular diagnosis of their need. TGS aims to develop novel and innovative epigenetic profiles hallmarking high-impact chronic and rare neurodevelopmental diseases to serve as early, preclinical, diagnostic verdicts of a disease. With the development of these novel tools, TGS aims to bridge the frequently large gap towards disease progression and therapeutic intervention. TGS provides novel epigenetic diagnostic methods for the early identification of pressing … Type: Startup Activities: deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 8 | |
Ocular Therapeutix, Inc. Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology, ELUTYXTM. Ocular Therapeutix has built a robust product pipeline of drug delivery solutions developed to reduce the complexity and burden of the current standard of care and position itself to become a leader in the ophthalmic space. Ocular Therapeutix has a commercially available drug product, DEXTENZA® (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use. DEXTENZA is an FDA-approved corticosteroid for the treatment of ocular inflammation and pain following … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 0 | 285 | |
Biotech Partners Biotech Partners is a life science recruiting company that's dedicated to solving people problems. We are Biotech Partners, one of the best d*mn life science recruitment agencies. We’re dedicated to solving people problems – it’s what we do. From biotechnology to clinical research, we take the bullsh*t out of job placement and connect real, qualified job seekers with employers in their field. Our specialty (beyond solving people problems) is all life science focused. Our search consultants have a complete understanding of what a successful hiring process will look like for you and your organization. Not only do we understand the … Type: SMB Activities: deeptech healthtech hrtech it services Technologies: Synthetic Biology | 0 | 0 | 0 | 8 | |
Spineart Quality. Innovation. Simplicity. Spineart is a privately held medical device company focused on accelerating technology adoption and elevating the standard of spinal care. As a global market leader in spine surgery, we support spine surgeons in over 60 markets worldwide and have introduced unique technologies in the field of minimally invasive surgery, motion preservation, fusion, biologics, fracture treatments, and more. Spineart offers a comprehensive portfolio of procedural solutions and technologies that combine traceable barcoded sterile-packed implants with compact instrument sets, ultimately promoting greater safety, cost-efficiency, and compliance for hospital systems worldwide. Spineart was awarded the "Prix de l'Economie Genevoise 2022" … Type: SMB Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology | 2 | 2 | 0 | 291 | |
Basilea Pharmaceutica For the benefit of patients Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in the heart of the life sciences hub of Basel area, Switzerland. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial and fungal infections. We have successfully launched two hospital brands: Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of severe bacterial infections. In addition, we have several preclinical anti-infective assets in our portfolio. Basilea currently has about 150 employees and is listed on the SIX Swiss Exchange (SIX: … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 1 | 0 | 211 | |
Medisolutions Medical devices for professionals Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 5 | 1 | 4 | 5 | |
3P Biopharmaceuticals We are now 3PBIOVIAN! Follow us on our new LinkedIn page, 3PBIOVIAN, to stay updated on all the latest developments and news! 3P Biopharmaceuticals and Biovian join forces to create 3PBIOVIAN, a leading pan-European biologics CDMO. Read more here: www.3pbiovian.com ***** 3PBIOVIAN is a globally operating Contract Development and Manufacturing Organization (CDMO), delivering end-to-end services for biotech and pharma companies. Our service offering includes microbial and mammalian protein expression platforms, viral vector production for adenoviruses and adeno-associated viruses, cell therapy, and plasmid DNA production. Additionally, we provide fill and finish services for recombinant proteins and viral vectors. With a combined … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 1 | 2 | 258 | |
MannKind Corporation Our mission is to give people control of their health and the freedom to live life. MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as diabetes, pulmonary arterial hypertension (PAH) and nontuberculous mycobacterial (NTM) lung disease. Our signature technologies – dry-powder formulations and inhalation devices – offer rapid and convenient delivery of medicines to the deep lung where … Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 4 | 0 | 3 | 562 | |
Enzymatica AB Enzymatica is a life science company whose business concept is to offer effective aid against some of our most common diseases where viruses or bacteria play a decisive role. Over a short period the company has developed a unique oral spray for common colds, ColdZyme® and launched it on four markets. The product became the leading article for common cold in Swedish pharmacies during winter 2014-2015. For product inf, please visit at www.coldzyme.co.uk. The development program includes medical devices in upper respiratory infections and oral health, and veterinary products. Cold and Flu, Enzyme (trypsin), and Barrier technology Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 25 | |
Registrar Corp Registrar Corp assists companies with U.S. FDA Regulations Registrar Corp provides U.S. FDA registration, U.S. agent, and regulatory compliance assistance for U.S. and non-U.S. companies in the food and beverage, medical device, drug, cosmetics, and radiation-emitting device industries. Registrar Corp provides expert assistance in 19 different languages, 24 hours per day, 7 days per week. Registrar Corp was founded in 2003 to assist businesses with compliance with U.S. Food and Drug Administration (U.S. FDA) regulations. Since opening its headquarters in Hampton, Virginia, USA, Registrar Corp has expanded to nineteen international offices and has aided more than 30,000 companies across 190 … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 0 | 5 | 265 | |
Personalized Stem Cells, Inc StemInsure®: Your Younger Cells For Life® Personalized Stem Cells, Inc. (PSC) is raising the standard of Stem Cell therapy. We are committed to providing high-quality stem cell processing services, as well as excellent technical, clinical, and regulatory support to physicians, clinical investigators, and patients. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 4 | |
Orphazyme A/S Our vision: To profoundly impact the lives of patients with orphan diseases and their families Orphazyme is a global biopharmaceutical company, headquartered in Denmark, with a rapidly growing presence in the United States. We are pioneering a new kind of treatment, applying our specialized expertise to bring innovative therapies to patients with neurodegenerative orphan diseases. With a late-stage drug pipeline, we are relentless in our commitment to advancing treatments and making a profound impact for those touched by these rare, serious diseases. Today we are listed on Nasdaq Copenhagen (TICKER: ORPHA.CO) and Nasdaq U.S. (TICKER: ORPH), and are expanding our … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 0 | 1 | 14 | |
novus med Surgical innovation, knowledge and reliability novus med are a UK medical device company specialising in the provision of Medical & Surgical innovation from around the globe. We seek out technological innovation that provides solutions to patients & clinicians that delivers sustainable value and cost savings to the healthcare system. To augment this, we pride ourselves in delivering unparalleled customer support. Products include : *Complete range of Laparoscopic Reusable, Resposable and Single-instruments *EMS Thulium Fibre Laser, LaserClast35 and LaserClast20 , Laser fibres *Hugemed - Single-Use Ureteroscope, Cystoscope, Choledochoscope * Full EndoUrology Portfolio - access sheaths, baskets, dilators, stents, irrigation *Mediflex range … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 9 | |
Zilico Limited Real-time medical diagnostics Zilico Ltd is a UK based company which specialises in the design and manufacture of real-time medical diagnostics to address specific clinical needs. ZedScanTM, Zilico's pioneering flagship product utilises Electrical Impedance Spectroscopy (EIS) to improve the ability to detect cervical intraepithelial neoplasia (CIN) following an abnormal cervical screening result, increasing diagnostic accuracy and delivering health economic benefits. Zilico’s patented EIS technology exploits the different electrical resistivity associated with the cellular structure of normal, pre-cancerous and cancerous tissue, which based on its applicability to other types of neoplasia, substantiates its use as a platform for the rapid, reliable … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 7 | 1 | 6 | 7 | |
NIOX® NIOX Group plc is a dedicated diagnostics and monitoring company focused on respiratory disease. NIOX Group plc is a company that specialises in the development, manufacture, and distribution of medical devices for the diagnosis and monitoring of asthma. Their flagship product, NIOX VERO®, is a non-invasive medical device that measures fractional exhaled nitric oxide (FeNO) levels in patients with asthma. NIOX VERO® provides accurate and reliable results, allowing healthcare professionals to make informed decisions about the diagnosis and management of asthma. It is easy to use, and can be used in a variety of settings, including clinics, hospitals, and primary … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 4 | 1 | 1 | 124 |